Device Trial Radar · NCT03949777
Validation of Aer-O-Scope Colonoscope System Cecal Intubation
Last checked: Nov 20, 2026Latest source record: Nov 18, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
79
Actual
Start
Jan 6, 2020
Primary completion
Aug 10, 2021
Study completion Nov 14, 2021
Sponsor
- Lead sponsor
- GI View Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- May 14, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 45 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
61 subjects (male or female) between the ages of 45 and 75 will undergo colonoscopy. The primary outcome is Cecal Intubation
Conditions
- Colonic Polyp
- Colonic Neoplasms
- Colonic Diseases
- Colon Adenoma
- Colon Disease
- Colon Adenocarcinoma
- Colon Cancer
Interventions
Aer-O-Scope ColonoscopyDevice
resection or biopsy of colonic abnormalities for histopathalogical evaluation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Aer-O-Scope Validation of Cecal IntubationTime frame: 30 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sourasky Medical Center
Tel Aviv, Israel
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.